Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears public testimony on cannabis omnibus DE; industry and patient advocates press competing fixes for hemp beverages, CBD and medical access
Summary
House members opened public testimony on the cannabis omnibus policy bill (HF 16-15 DE) on April 2; nonpartisan staff, the Office of Cannabis Management, industry representatives and patient advocates addressed medical, adult-use and hemp provisions.
House File 16-15 (DE) — the committee's cannabis omnibus policy bill — received an article-by-article walk-through April 2, and the committee took public testimony during a lengthy public-comment period. The DE was divided into three articles: Article 1 (medical cannabis technical changes), Article 2 (adult-use licensing and related provisions, including testing facility licensing variances), and Article 3 (hemp business regulations, including lower-potency hemp beverage licensing).
Ben Johnson of House Research provided a high-level overview. He said the DE pulls together provisions the committee previously considered and includes limited changes to medical program statute (chapter 152) and corrections or technical edits in licensing and hemp regulation. "The House file 16-15 DE is divided…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
